StockData

NanoViricides, Inc. (NNVC) income statement

NNVCNYSEPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$1.19+0.03 (+2.59%)

Close on Nov 18, 2026Market cap $30.37MP/E –Yield –

NanoViricides, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2026
-101.5%

Financial strength

Current ratio
2.66
Debt to equity
–
Debt to assets
–
Cash to current liabilities
234.7%

Valuation

P/E ratio
–
Price to sales
–
Price to book
3.50
Dividend yield
–

See a number that looks wrong?